Lucerna, Inc.

Lucerna, Inc., is a biotechnology research company focused on developing and commercializing nucleic-acid based fluorescent sensors for Point-of-Care therapeutic diagnostics and environmental biomonitoring. Lucerna also offers newly developed antibodies for proteomic research.

NYAG, LLC (Crunch Time Apple Growers)

NYAG (New York Apple Growers), LLC, was formed around an exclusive license agreement for two new apple varieties, ‘New York 1’ and ‘New York 2’. This member owned company is open to all New York growers to help promote agricultural market growth within New York state.

SightSpeed, Inc.

SightSpeed, Inc., provides high quality, feature rich, and easy-to-use Internet video communications services for both businesses and consumers. SightSpeed, Inc., was acquired by Logitech, Inc., in October 2008.

Lumidyne Technologies, LLC

Lumidyne develops next-generation fluorescent probes exhibiting superior brightness and stability compared with current commercially available reagents.

NOHMs Technologies, Inc.

NOHMs Technologies, Inc., is a battery materials manufacturer (anode, cathode, and electrolyte) with a vision to improve and commercialize promising new nanoscale chemistry for better battery technology.

Angiocrine Bioscience, Inc.

Angiocrine Bioscience, Inc., is developing both research and therapeutic products using stem and endothelial cell related technologies.

WOTN, LLC

WOTN is a risk software company that provides an independent, real-time, simulation-based risk management platform for the $1T commercial mortgage backed securities market. The patent pending technology provides risk measurements on demand for loans and bonds in the derivative structure compliant with Basel in a comprehensive portfolio management system.

TeraPore Technologies, Inc.

TeraPore Technologies, Inc. develops membrane technologies for high-permeability, high-resolution separations including purification of biological fluids.

Immunovent, LLC

Immunovent, LLC is focused on the commercialization of next-generation technologies for allergy diagnosis. The company is developing the Local Allergy Mucosal Brush Test (LAMB-Dx), the first quantitative allergy diagnostic that will enable physicians to accurately test for both airborne and food allergies precisely where the clinical symptoms are occurring – in the mouth and nose.

ZYMtronix, Inc.

ZYMtronix is a biotechnology startup that services enzyme and pharmaceutical manufacturers. ZYMtronix immobilizes and optimizes biocatalysts for continuous manufacturing using green chemistry principles to lower the costs and increase the yields of drug manufacturing.